查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
脑膜炎诊断测试市场规模,份额和趋势分析报告：按测试类型（乳胶凝集试验,侧向流动试验,PCR试验,ELISA试验,培养试验）,最终用户,地区细分市场预测2023-2030
市场调查报告书
商品编码
1171099

脑膜炎诊断测试市场规模,份额和趋势分析报告：按测试类型（乳胶凝集试验,侧向流动试验,PCR试验,ELISA试验,培养试验）,最终用户,地区细分市场预测2023-2030

Meningitis Diagnostic Testing Market Size, Share & Trends Analysis Report By Test Type (Latex Agglutination Tests, Lateral Flow Assay, PCR Assay, ELISA Tests, Culture Test), By End-user, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

脑膜炎诊断测试市场的增长和趋势

根据 Grand View Research, Inc 的最新报告，到 2030 年，全球脑膜炎诊断测试市场规模预计将达到 1.5406 亿美元，预测期内的复合年增长率为 3.68%。 市场的增长归因于公众对疾病早期诊断意识的提高以及对快速诊断和高精度测试的需求增加。 此外，政府加大对减轻疾病负担的支持以及诊断中心数量的增加也在推动市场需求。

传染病和 HIV 的传播增加了患脑膜炎的风险，增加了全世界对脑膜炎诊断测试的需求。 例如，据世界卫生组织称，到 2021 年，全世界将有超过 3840 万人感染艾滋病毒。 此外，根据 CDC 的数据，2020 年美国约有 30,635 人被诊断出患有 HIV，大量 HIV 感染者可能会提高脑膜炎的检测率。 此外，估计 EV 脑膜炎每年在美国导致大约 30,000 至 50,000 人住院。

相关疾病的高发病率促使製造商开发准确的诊断解决方案。 例如，Cepheid 提供 Xpert EV，这是一种快速分子体外诊断，可在 2.5 小时内提供具有最佳灵敏度和特异性的结果。 同样，Diagenode Diagnostics 的 M-DiaMult 是一种 PCR-CE-IVD 试剂盒，可检测多种细菌感染，包括脑膜炎奈瑟菌。

由于其长期影响和高死亡率，脑膜炎是一个全球性问题。 各国政府正在积极支持提供先进的诊断测试和治疗以根除脑膜炎。 例如，脑膜炎研究基金会和疾病预防控制中心为许多医院无法提供的传染病提供诊断服务，例如肺结核、疟疾和脑膜炎。 因此，政府促进各种传染病诊断的努力可能会为市场提供有利可图的增长机会。

此外，医疗保健行业的迅猛发展和诊断测试技术的不断进步预计将为市场提供强劲的增长机会。 例如，2022 年 7 月，分子诊断检测的领导者 Abacus Diagnostica 在欧洲市场推出了一种新的快速 PCR 检测，用于快速识别引起脑炎和脑膜炎的病毒。 这项新推出的测试使医疗保健专业人员能够在短短 70 分钟内识别出引起脑膜炎的最常见病毒。 高精度和快速测试的引入预计将推动未来几年的市场增长。

脑膜炎诊断测试市场报告要点

由于对 PCR 测试的高度偏好、高灵敏度和低测试周转时间，PCR 检测部分在 2022 年占据了最大的市场份额

随着快速检测在各种医疗机构中的持续增长，预计未来几年横向流动检测将以最快的速度增长

医院部门是基准年销售额的最大贡献者，销售额增加归因于新诊断技术的普及和健康覆盖率的提高

由于传染病的激增和先进产品的日益采用，预计诊断中心部分将呈现最快的增长速度

由于该地区临床试验的投资增加和进展，预计亚太地区在预测期内将呈现最快的增长

内容

第1章调查方法及范围

  • 市场细分和范围
    • 细分范围
    • 区域范围
  • 调查方法
  • 信息采购
    • 购买的数据库：
    • GVR 内部数据库
    • 次要信息
    • 初步调查
    • 初步调查的内容
  • 信息或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细信息
    • 商品流分析
      • 方法：产品流方法
  • 调查假设
  • 二级信息列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场展望
  • 竞争考虑

第 3 章脑膜炎诊断测试市场变量、趋势和范围

  • 市场系列展望
    • 母公司市场
  • 市场动态
    • 市场驱动因素分析
      • 脑膜炎患病率增加
      • 创新技术对快速诊断的需求不断增长
      • 政府大力支持控制脑膜炎球菌病爆发
    • 市场製约因素分析
      • 严格的监管框架
  • 描绘渗透率和增长前景
  • 脑膜炎诊断测试：市场分析工具
    • 行业分析 - 搬运工
    • PESTLE 分析
  • 监管框架
  • 价格分析

第 4 章。按测试类型分列的脑膜炎诊断测试市场细分分析，2018-2030（百万美元）

  • 定义和范围
  • 2022 年和 2030 年测试类型市场份额分析
  • 部门仪表板
  • 2018-2030 年按测试类型分列的全球脑膜炎诊断测试市场
  • 2018-2030 年市场规模和预测、趋势分析
    • 乳胶絮凝
    • 侧流分析
    • PCR 检测
    • ELISA 测试
    • 文化测试
    • 其他

第 5 章。脑膜炎诊断测试市场细分分析，按最终用户，2018-2030 年（百万美元）

  • 定义和范围
  • 2022 年和 2030 年最终用户市场份额分析
  • 部门仪表板
  • 全球脑膜炎诊断测试市场，按最终用户划分，2018-2030 年
  • 2018-2030 年市场规模和预测、趋势分析
    • 医院
    • 诊断中心
    • 其他

第 6 章脑膜炎诊断测试市场细分分析，按地区划分，2018-2030 年（百万美元）

  • 定义和范围
  • 2022 年和 2030 年区域市场份额分析
  • 区域市场仪表板
  • 区域市场概况
  • SWOT 分析
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 2018-2030 年市场规模、预测、收入和趋势分析
    • 北美
      • 美国
      • 加拿大
    • 欧洲
      • 英国
      • 德国
      • 西班牙
      • 法国
      • 意大利
      • 丹麦
      • 瑞典
      • 挪威
    • 亚太地区
      • 日本
      • 中国
      • 印度
      • 韩国
      • 澳大利亚
      • 泰国
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 阿根廷
    • 多边环境协定
      • 南非
      • 沙特阿拉伯
      • 阿拉伯联合酋长国
      • 科威特

第 7 章。脑膜炎诊断测试市场 - 竞争分析

  • 主要市场进入者的近期趋势和影响分析
    • 安索夫矩阵
    • 热图分析
    • 主要交易和战略联盟分析
      • 合资企业
      • 许可协议
      • 产品发布
      • 会议和活动
  • 公司分类
    • 创新者
    • 市场领导者
  • 供应商情况
    • 主要分销商和渠道合作伙伴列表
    • 主要客户
  • 上市公司
    • 竞争仪表板分析
      • 市场差异化因素
  • 私人公司
    • 主要初创公司名单
  • 公司简介
    • Thermo Fisher Scientific, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Bio-Rad Laboratories, Inc.
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 雅培
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • ELI 科技集团
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Seegene 公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Luminex 公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • CERTEST BIOTEC
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • 伊米
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
    • Unigen 公司
      • 公司简介
      • 财务业绩
      • 产品基准
      • 战略举措
Product Code: GVR-4-68040-009-0

Meningitis Diagnostic Testing Market Growth & Trends:

The global meningitis diagnostic testing market size is expected to reach USD 154.06 million by 2030, according to a new report by Grand View Research, Inc, registering a CAGR of 3.68% over the forecast period. The growth of the market is accredited to the rising awareness among the people about early disease diagnosis and increasing demand for rapid diagnosis coupled with the high accuracy of the test. Moreover, the increasing government support to reduce the burden of disease and the rising number of diagnostic centers are other factors fueling market demand.

The increasing prevalence of infectious diseases, and HIV is increasing the risk of developing meningitis, which is increasing the demand for meningitis diagnostic tests, worldwide. For instance, according to the WHO, over 38.4 million people were living with HIV worldwide in 2021. In addition, according to CDC in 2020, around 30,635 people received HIV diagnoses in the U.S. High number of HIV infections may increase the testing rate for meningitis. Moreover, EV meningitis is estimated to result in around 30,000-50,000 hospitalizations every year in the U.S.

Thus, such a high incidence of target diseases is pushing manufacturers to develop precise diagnostic solutions. For instance, Cepheid offered Xpert EV, a fast molecular in vitro diagnostic EV test, which provides results in 2.5 hours with optimum sensitivity and specificity. Similarly, M-DiaMult of Diagenode Diagnostics is a type of PCR- CE-IVD kit that detects many bacterial infections including Neisseria meningitidis.

Meningitis infection has emerged as a global issue owing to its long-term consequences and high mortality rate. The government is offering active support to provide sophisticated diagnostic tests and treatment regimens to eradicate the disease. For instance, the Meningitis Research Foundation and the CDC offer referral diagnoses for different infectious diseases such as tuberculosis, malaria, and meningitis among others that are not available in hospitals. Thus, such government initiatives to promote the diagnosis of various infectious diseases are likely to offer lucrative growth opportunities for the market.

Furthermore, the surge in the healthcare sector developments and growing technological advancements in diagnostic tests are likely to offer robust growth opportunities for the market. For instance, in July 2022, Abacus Diagnostica, a leader in molecular diagnostic testing, launched a novel rapid PCR test in Europe markets for the quick identification of viruses causing encephalitis and meningitis. This newly launched test allows healthcare professionals to identify the most common virus those causes meningitis in a span of 70 minutes. The introduction of rapid tests with high accuracy is anticipated to propel the market growth in the coming years.

Meningitis Diagnostic Testing Market Report Highlights:

  • PCR assay segment held the largest market share in 2022 owing to a high preference for PCR tests and higher sensitivity and lower turnaround times of the test
  • Lateral flow assay is expected to be the fastest segment during the coming years due to the increasing adoption of rapid tests at different healthcare facilities
  • Hospitals segment was the leading revenue contributor during the base year and its high revenue is attributed to increasing access to novel diagnostic technologies and improved healthcare coverage
  • The diagnostic centers segment is anticipated to exhibit the fastest growth rate owing to the surge in the burden of infectious diseases and the increasing adoption of technologically advanced products
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to rising investments in the region and ongoing trials in the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation and Scope
    • 1.1.1 Segment scope
    • 1.1.2 Regional scope
    • 1.1.3 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased database:
    • 1.3.2 GVR's internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis
      • 1.6.1.1 Approach: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List of Secondary Sources
  • 1.9 List of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Competitive Insights

Chapter 3 Meningitis Diagnostic Testing Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market
  • 3.2 Market Dynamics
    • 3.2.1 Market drivers analysis
      • 3.2.1.1 Increasing prevalence of meningitis
      • 3.2.1.2 Rise in demand for rapid diagnosis by using innovative technologies
      • 3.2.1.3 Active government support to control meningitis disease outbreak
    • 3.2.2 Market restraint analysis
      • 3.2.2.1 Stringent regulatory framework
  • 3.3 Penetration & Growth Prospect Mapping
  • 3.4 Meningitis Diagnostic Testing: Market Analysis Tools
    • 3.4.1 Industry analysis - Porter's
    • 3.4.2 PESTLE analysis
  • 3.5 Regulatory Framework
  • 3.6 Pricing Analysis

Chapter 4 Meningitis Diagnostic Testing Market Segment Analysis, By Test Type, 2018 - 2030 (USD Million)

  • 4.1 Definition and Scope
  • 4.2 Test Type Market Share Analysis, 2022 & 2030
  • 4.3 Segment Dashboard
  • 4.4 Global Meningitis Diagnostic Testing Market, by Test Type, 2018 to 2030
  • 4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.5.1 Latex Agglutination
      • 4.5.1.1 Latex agglutination market, 2018 - 2030 (USD million)
    • 4.5.2 Lateral Flow Assay
      • 4.5.2.1 Lateral flow assay market, 2018 - 2030 (USD million)
    • 4.5.3 PCR Assay
      • 4.5.3.1 PCR assay market, 2018 - 2030 (USD million)
    • 4.5.4 ELISA Tests
      • 4.5.4.1 ELISA tests market, 2018 - 2030 (USD million)
    • 4.5.5 Culture Test
      • 4.5.5.1 Culture test market, 2018 - 2030 (USD million)
    • 4.5.6 Others
      • 4.5.6.1 Others market, 2018 - 2030 (USD million)

Chapter 5 Meningitis Diagnostic Testing Market Segment Analysis, By End-User 2018 - 2030 (USD Million)

  • 5.1 Definition and Scope
  • 5.2 End-User Market Share Analysis, 2022 & 2030
  • 5.3 Segment Dashboard
  • 5.4 Global Meningitis Diagnostic Testing Market, by End-User, 2018 to 2030
  • 5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.5.1 Hospitals
      • 5.5.1.1 Hospitals market, 2018 - 2030 (USD million)
    • 5.5.2 Diagnostic Centers
      • 5.5.2.1 Diagnostic centers market, 2018 - 2030 (USD million)
    • 5.5.3 Others
      • 5.5.3.1 Others market, 2018 - 2030 (USD million)

Chapter 6 Meningitis Diagnostic Testing Market Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 6.1 Definition & Scope
  • 6.2 Regional Market Share Analysis, 2022 & 2030
  • 6.3 Regional Market Dashboard
  • 6.4 Regional Market Snapshot
  • 6.5 SWOT Analysis
    • 6.5.1 North America
    • 6.5.2 Europe
    • 6.5.3 Asia Pacific
    • 6.5.4 Latin America
    • 6.5.5 Middle East and Africa
  • 6.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2018 to 2030
    • 6.6.1 North America
      • 6.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD million)
      • 6.6.1.2 U.S.
      • 6.6.1.2.1 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.1.3 Canada
      • 6.6.1.3.1 Canada meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.2 Europe
      • 6.6.2.1 Europe meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.2 U.K.
      • 6.6.2.2.1 U.K. meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.3 Germany
      • 6.6.2.3.1 Germany meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.4 Spain
      • 6.6.2.4.1 Spain meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.5 France
      • 6.6.2.5.1 France meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.6 Italy
      • 6.6.2.6.1 Italy meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.7 Denmark
      • 6.6.2.7.1 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.8 Sweden
      • 6.6.2.8.1 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.2.9 Norway
      • 6.6.2.9.1 Norway meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.3 Asia Pacific
      • 6.6.3.1 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.2 Japan
      • 6.6.3.2.1 Japan meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.3 China
      • 6.6.3.3.1 China meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.4 India
      • 6.6.3.4.1 India meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.5 South Korea
      • 6.6.3.5.1 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.6 Australia
      • 6.6.3.6.1 Australia meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.3.7 Thailand
      • 6.6.3.7.1 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.4 Latin America
      • 6.6.4.1 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.4.2 Brazil
      • 6.6.4.2.1 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.4.3 Mexico
      • 6.6.4.3.1 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.4.4 Argentina
      • 6.6.4.4.1 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD million)
    • 6.6.5 MEA
      • 6.6.5.1 MEA meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.2 South Africa
      • 6.6.5.2.1 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.3 Saudi Arabia
      • 6.6.5.3.1 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.4 UAE
      • 6.6.5.4.1 UAE meningitis diagnostic testing market, 2018 - 2030 (USD million)
      • 6.6.5.5 Kuwait
      • 6.6.5.5.1 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD million)

Chapter 7 Meningitis Diagnostic Testing Market - Competitive Analysis

  • 7.1 Recent Developments & Impact Analysis, by Key Market Participants
    • 7.1.1 Ansoff matrix
    • 7.1.2 Heat map analysis
    • 7.1.3 Major Deals and Strategic Alliances Analysis
      • 7.1.3.1 Joint Ventures
      • 7.1.3.2 Licensing Agreements
      • 7.1.3.3 Product Launches
      • 7.1.3.1 Conferences and Campaigns
  • 7.2 Company Categorization
    • 7.2.1 Innovators
    • 7.2.2 Market Leaders
  • 7.3 Vendor Landscape
    • 7.3.1 List of key distributors and channel partners
    • 7.3.2 Key customers
  • 7.4 Public Companies
    • 7.4.1 Competitive Dashboard Analysis
      • 7.4.1.1 Market Differentiators
  • 7.5 Private Companies
    • 7.5.1 List of key emerging companies
  • 7.6 Company Profiles
    • 7.6.1 Thermo Fisher Scientific, Inc.
      • 7.6.1.1 Company overview
      • 7.6.1.2 Financial performance
      • 7.6.1.3 Product benchmarking
      • 7.6.1.4 Strategic initiatives
    • 7.6.2 Bio-Rad Laboratories, Inc.
      • 7.6.2.1 Company overview
      • 7.6.2.2 Financial performance
      • 7.6.2.3 Product benchmarking
      • 7.6.2.4 Strategic initiatives
    • 7.6.3 Abbott
      • 7.6.3.1 Company overview
      • 7.6.3.2 Financial performance
      • 7.6.3.3 Product benchmarking
      • 7.6.3.4 Strategic initiatives
    • 7.6.4 ELITechGroup
      • 7.6.4.1 Company overview
      • 7.6.4.2 Financial performance
      • 7.6.4.3 Product benchmarking
      • 7.6.4.4 Strategic initiatives
    • 7.6.5 Seegene Inc.
      • 7.6.5.1 Company overview
      • 7.6.5.2 Financial performance
      • 7.6.5.3 Product benchmarking
      • 7.6.5.4 Strategic initiatives
    • 7.6.6 Luminex Corporation
      • 7.6.6.1 Company overview
      • 7.6.6.2 Financial performance
      • 7.6.6.3 Product benchmarking
      • 7.6.6.4 Strategic initiatives
    • 7.6.7 CERTEST BIOTEC
      • 7.6.7.1 Company overview
      • 7.6.7.2 Financial performance
      • 7.6.7.3 Product benchmarking
      • 7.6.7.4 Strategic initiatives
    • 7.6.8 IMMY
      • 7.6.8.1 Company overview
      • 7.6.8.2 Financial performance
      • 7.6.8.3 Product benchmarking
      • 7.6.8.4 Strategic initiatives
    • 7.6.9 Uniogen Oy
      • 7.6.9.1 Company overview
      • 7.6.9.2 Financial performance
      • 7.6.9.3 Product benchmarking
      • 7.6.9.4 Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Leading Market Players Anticipated to Witness Highest Growth
  • Table 4 Global Meningitis Diagnostic Testing Market, By Region, 2018 - 2030 (USD Million)
  • Table 5 Global Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 6 Global Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 7 North America Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 8 North America Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 9 North America Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 10 U.S. Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 11 U.S. Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 12 Canada Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 13 Canada Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 14 Europe Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 15 Europe Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 16 Europe Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 17 U.K. Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 18 U.K. Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 19 Germany Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 20 Germany Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 21 France Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 22 France Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 23 Spain Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 24 Spain Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 25 Italy Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 26 Italy Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 27 Denmark Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 28 Denmark Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 29 Norway Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 30 Norway Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 31 Sweden Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 32 Sweden Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 36 Japan Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 37 Japan Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 38 China Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 39 China Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 40 India Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 41 India Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 42 Australia Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 43 Australia Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 44 South Korea Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 45 South Korea Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 46 Thailand Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 47 Thailand Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 48 Latin America Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 49 Latin America Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 50 Latin America Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 51 Brazil Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 52 Brazil Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 53 Argentina Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 54 Argentina Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 55 Mexico Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 56 Mexico Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 57 Middle East and Africa Meningitis Diagnostic Testing Market, By Country, 2018 - 2030 (USD Million)
  • Table 58 Middle East and Africa Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 59 Middle East and Africa Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 60 South Africa Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 61 South Africa Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 62 Saudi Arabia Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 63 Saudi Arabia Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 64 UAE Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 65 UAE Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)
  • Table 66 Kuwait Meningitis Diagnostic Testing Market, By Test Type, 2018 - 2030 (USD Million)
  • Table 67 Kuwait Meningitis Diagnostic Testing Market, By End-User, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Meningitis diagnostic testing market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2022)
  • Fig. 10 Strategy framework
  • Fig. 11 Market driver relevance analysis (Current & future impact)
  • Fig. 12 Market restraint relevance analysis (Current & future impact)
  • Fig. 13 Penetration & growth prospect mapping
  • Fig. 14 Porter's five forces analysis
  • Fig. 15 PESTLE analysis
  • Fig. 16 Meningitis Diagnostic Testing market: Test type movement analysis
  • Fig. 17 Meningitis Diagnostic Testing market: Test type segment dashboard
  • Fig. 18 Meningitis Diagnostic Testing market Test type outlook: Key takeaways
  • Fig. 19 Latex agglutination market, 2018 - 2030 (USD million)
  • Fig. 20 Lateral flow assay market, 2018 - 2030 (USD million)
  • Fig. 21 PCR assay market, 2018 - 2030 (USD million)
  • Fig. 22 ELISA tests market, 2018 - 2030 (USD million)
  • Fig. 23 Culture test market, 2018 - 2030 (USD million)
  • Fig. 24 Others market, 2018 - 2030 (USD million)
  • Fig. 25 Meningitis Diagnostic Testing market: End-user analysis
  • Fig. 26 Meningitis Diagnostic Testing market: End-user segment dashboard
  • Fig. 27 Meningitis Diagnostic Testing market End-user outlook: Key takeaways
  • Fig. 28 Hospitals market, 2018 - 2030 (USD million)
  • Fig. 29 Diagnostic centers market, 2018 - 2030 (USD million)
  • Fig. 30 Others market, 2018 - 2030 (USD million)
  • Fig. 31 Regional outlook, 2022 & 2030
  • Fig. 32 Regional market dashboard
  • Fig. 33 Regional market place: Key takeaways
  • Fig. 34 North America, SWOT
  • Fig. 35 Europe, SWOT
  • Fig. 36 Asia Pacific, SWOT
  • Fig. 37 Latin America, SWOT
  • Fig. 38 Middle East and Africa, SWOT
  • Fig. 39 North America
  • Fig. 40 North America meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 41 U.S.
  • Fig. 42 U.S. meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 43 Canada
  • Fig. 44 Canada meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 45 Europe
  • Fig. 46 Europe meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 47 U.K.
  • Fig. 48 U.K. meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 49 Germany
  • Fig. 50 Germany meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 51 Spain
  • Fig. 52 Spain meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 53 France
  • Fig. 54 France meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 55 Italy
  • Fig. 56 Italy meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 57 Denmark
  • Fig. 58 Denmark meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 59 Sweden
  • Fig. 60 Sweden meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 61 Norway
  • Fig. 62 Norway meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 63 Asia Pacific
  • Fig. 64 Asia Pacific meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 65 Japan
  • Fig. 66 Japan meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 67 China
  • Fig. 68 China meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 69 India
  • Fig. 70 India meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 71 South Korea
  • Fig. 72 South Korea meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 73 Australia
  • Fig. 74 Australia meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 75 Thailand
  • Fig. 76 Thailand meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 77 Latin America
  • Fig. 78 Latin America meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 79 Brazil
  • Fig. 80 Brazil meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 81 Mexico
  • Fig. 82 Mexico meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 83 Argentina
  • Fig. 84 Argentina meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 85 Middle East and Africa
  • Fig. 86 MEA meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 87 South Africa
  • Fig. 88 South Africa meningitis diagnostic testing market, 2018 - 2030 (USD Million)
  • Fig. 89 Saudi Arabia
  • Fig. 90 Saudi Arabia meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 91 UAE
  • Fig. 92 UAE meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 93 Kuwait
  • Fig. 94 Kuwait meningitis diagnostic testing market, 2018 - 2030 (USD million)
  • Fig. 95 Ansoff Matrix
  • Fig. 96 Heat map analysis
  • Fig. 97 Market differentiators